Provided by Tiger Fintech (Singapore) Pte. Ltd.

Beam Therapeutics, Inc.

19.87
+0.74003.87%
Post-market: 20.000.1300+0.65%17:19 EDT
Volume:2.13M
Turnover:43.17M
Market Cap:2.00B
PE:-4.34
High:20.81
Open:20.00
Low:19.85
Close:19.13
Loading ...

Beam Therapeutics Advances BEAM-101 Therapy for Sickle Cell

TIPRANKS
·
09 Dec 2024

Analysts’ Top Healthcare Picks: Stoke Therapeutics (STOK), Beam Therapeutics (BEAM)

TIPRANKS
·
09 Dec 2024

William Blair Remains a Buy on Beam Therapeutics (BEAM)

TIPRANKS
·
09 Dec 2024

Beam Therapeutics Says Conditioning Platform Shows Potential in Sickle Cell Disease Treatment

MT Newswires Live
·
09 Dec 2024

Beam presents new NHP data demonstrating proof-of-concept for ESCAPE

TIPRANKS
·
09 Dec 2024

Beam Therapeutics announces new data from BEACON Phase 1/2 trial of BEAM-101

TIPRANKS
·
08 Dec 2024

BRIEF-Beam Therapeutics Says All 7 Patients Treated With Beam-101 Achieved Durable Increases In Fetal Hemoglobin, Reductions In Sickle Hemoglobin

Reuters
·
08 Dec 2024

Beam Therapeutics Announces New Data From Beacon Phase 1/2 Clinical Trial of Beam-101 in Sickle Cell Disease at American Society of Hematology (Ash) Annual Meeting

THOMSON REUTERS
·
08 Dec 2024

Beam Therapeutics: Initial Safety Profile Consistent With Busulfan Conditioning and Autologous Hematopoietic Stem Cell Transplantation

THOMSON REUTERS
·
08 Dec 2024

Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting

GlobeNewswire
·
08 Dec 2024

Beam Therapeutics: All 7 Patients Treated With Beam-101 Achieved Durable Increases in Fetal Hemoglobin, Reductions in Sickle Hemoglobin

THOMSON REUTERS
·
08 Dec 2024

Aethir, Beam, and MetaStreet to Launch $40 Million AI Compute Initiative

BE[IN]CRYPTO
·
07 Dec 2024

Stock Market Rallies On: AI Software, Biotechs, Costco Coming Up

Blockhead
·
07 Dec 2024

Beam Therapeutics Names Sravan K. Emany as CFO

TIPRANKS
·
06 Dec 2024

Beam Therapeutics Appoints Sravan Emany as CFO

MT Newswires Live
·
06 Dec 2024

Beam Therapeutics Names Sravan Emany Chief Financial Officer

Dow Jones
·
06 Dec 2024

Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer

THOMSON REUTERS
·
06 Dec 2024

Why Is Beam Therapeutics (BEAM) Down 2.3% Since Last Earnings Report?

Zacks
·
06 Dec 2024

Beam Therapeutics Strengthens Board with Pharma Veteran

TIPRANKS
·
04 Dec 2024

Beam Therapeutics Expands Its Board of Directors With Appointment of Chirfi Guindo, Global Biopharma Strategy and Commercial Leader

THOMSON REUTERS
·
04 Dec 2024